Aligos Therapeutics, Inc. - (ALGS) share price
Aligos Therapeutics, Inc. - (NASDAQ:ALGS) last traded at $4.07, down 9.76% on the day (quote 2026-11-06 21:00 UTC), with a market cap of $0.03B and a 52-week range of $3.98 to $13.69.
| Exchange | NASDAQ |
|---|---|
| Currency | USD |
| Last price | $4.07 |
| 1-day move | -9.76% |
| 52-week range | $3.98 - $13.69 |
| Market cap | $0.03B |
| From 52-week high | -70.30% |
| Volume vs average | 1.7x |
| Falling Shares risk score | 72/100 (CRITICAL) |
| Country | United States |
Frequently asked questions
Why is Aligos Therapeutics, Inc. - falling today?
Aligos Therapeutics, Inc. - (NASDAQ:ALGS) is down 9.76% at its latest quote and trades 70.3% below its 52-week high, on volume 1.7x its average. A price fall alone does not identify a cause: Falling Shares Intelligence links a move to a filing, order or news item only when a source supports it.
What is the Aligos Therapeutics, Inc. - share price today?
Aligos Therapeutics, Inc. - (NASDAQ:ALGS) last traded at $4.07, a -9.76% move on the day as of 2026-11-06 21:00 UTC. Market data comes from public feeds and may be delayed; it is not investment advice.
What is the 52-week range of Aligos Therapeutics, Inc. -?
Aligos Therapeutics, Inc. -'s 52-week low is $3.98 and its 52-week high is $13.69; the shares trade 70.3% below the high.
What is the market cap of Aligos Therapeutics, Inc. -?
Aligos Therapeutics, Inc. - has a market capitalisation of about $0.03B at the latest price.
What are the risks of investing in Aligos Therapeutics, Inc. -?
Falling Shares Intelligence rates Aligos Therapeutics, Inc. - 72/100 (CRITICAL) on price stress, volume and disclosure signals. Risk scores are analytical indicators, not allegations or investment advice. Review exchange filings and the company's own disclosures before any decision.
Data is compiled from public exchange feeds and may be delayed. Not investment advice.
Wung Thomas, Editor-in-Chief: wungthomas@fallingshares.com. General enquiries and corrections: info@fallingshares.com